Your browser doesn't support javascript.
loading
Mostrar: 20 | 50 | 100
Resultados 1 - 3 de 3
Filtrar
Más filtros










Base de datos
Intervalo de año de publicación
1.
J Clin Psychol ; 79(5): 1328-1341, 2023 05.
Artículo en Inglés | MEDLINE | ID: mdl-36649584

RESUMEN

INTRODUCTION: The use of humor in psychotherapy is widely considered to improve therapy outcomes and typically depends on context, patient sensitivity, and the therapist's humor style. Different types of humor may impact treatment type, therapeutic alliance, and therapy outcome; however, evidence from psychotherapy sessions on the role of banter has been sparse to date. Therefore, the study aims to examine banter in a secondary analysis of psychotherapy sessions. METHOD: The sample consisted of 68 depressed outpatients treated with one of three treatment types: psychoanalytic therapy (PA), psychodynamic therapy (PD), and cognitive-behavioral therapy (CBT). Banter and therapeutic alliance were rated for therapy sessions taken from the middle phase of treatment, outcome was assessed at the end of treatment. RESULTS: The main findings were (1) clinical examples of banter in psychotherapy were found in 62 from 68 sessions, (2) significantly more bantering in the main bantering category of facilitation for CBT sessions as compared to other treatment types, (3) facilitative banter as a significant predictor for the positive introject, (4) a significant correlation between bantering and bond between therapist and client. Furthermore, based on these results, psychometric properties of the Klagenfurt Bantering Instrument (KBI) are reported. CONCLUSION: From a bantering perspective, this study emphasizes the need to consider session context, client response, and sarcastic markers when categorizing negative banter using the KBI.


Asunto(s)
Terapia Cognitivo-Conductual , Terapia Psicoanalítica , Psicoterapia Psicodinámica , Alianza Terapéutica , Humanos , Psicoterapia/métodos , Terapia Cognitivo-Conductual/métodos , Resultado del Tratamiento , Relaciones Profesional-Paciente
2.
BMJ Case Rep ; 11(1)2018 Dec 22.
Artículo en Inglés | MEDLINE | ID: mdl-30580303

RESUMEN

It is well known that up to 2% of chronic burn scar lesions can transform into malignant tumours, however, melanoma formation at these sites is extremely rare. This case report describes a burns case, which progressed to four melanomas in a 78-year-old male patient's little finger, 40 years after the initial incident. The patient underwent 3 mm punch biopsies, then digital amputation of the finger with pathology-proven melanoma. Histopathology investigation demonstrated three melanoma in situ and one invasive melanoma with a Breslow thickness of 1 mm. These findings are rare with few reports of melanoma in burn scars in the literature. This case report highlights the vigilance required from clinicians when performing skin examinations, and the importance of biopsies to newly pigmented lesions.


Asunto(s)
Quemaduras/complicaciones , Cicatriz/complicaciones , Melanoma/etiología , Neoplasias Primarias Múltiples/etiología , Anciano , Quemaduras/patología , Cicatriz/patología , Dedos/patología , Humanos , Masculino , Melanoma/patología , Neoplasias Primarias Múltiples/patología
3.
J Androl ; 32(4): 375-82, 2011.
Artículo en Inglés | MEDLINE | ID: mdl-21127308

RESUMEN

Priapism is defined as a prolonged, persistent, and purposeless penile erection. It is a common (35%) but frequently understated complication in young men and adults with sickle cell disease. We had previously demonstrated an association between stuttering attacks (<4 hours) and an acute catastrophic event with its consequent problems of erectile dysfunction and impotence. We describe a randomized, placebo-controlled, clinical study looking at medical prophylaxis with 2 oral α-adrenergic agonists, etilefrine and ephedrine, in preventing stuttering attacks of priapism. One hundred thirty-one patients were registered into a 2-phase (observational and intervention phase) study, and 86 patients (66%) completed Phase A diary charts. Forty-six patients (59%) completed a 6-month treatment phase (Phase B), and the remaining patients were lost to follow-up despite persistent efforts to contact them. Various reasons are postulated for the high attrition rates. The drugs were well tolerated, and no serious adverse events were reported. There was no significant difference among the 4 treatment groups in the weekly total number of attacks in Phase B (analysis of covariance P = .99) nor among the average pain score per attack after adjusting for attack rates and pain scores in Phase A (analysis of covariance P = .33). None of the patients who completed the study required penile aspiration at study sites while on medical prophylaxis. Young men with sickle cell disease are not comfortable engaging with health care providers about issues relating to their sexual health. The full impact of an improved awareness campaign and early presentation to hospital merits further standardized study. Priapism still contributes seriously to the comorbidity experienced by this previously inaccessible group of patients and medical prophylaxis with oral α-adrenergic agonists is feasible. Future international collaborative efforts using some of the lessons learnt in this study should be undertaken.


Asunto(s)
Agonistas de Receptores Adrenérgicos alfa 2/uso terapéutico , Anemia de Células Falciformes/complicaciones , Priapismo/tratamiento farmacológico , Tartamudeo/complicaciones , Adolescente , Adulto , Efedrina/uso terapéutico , Disfunción Eréctil/etiología , Etilefrina/efectos adversos , Etilefrina/uso terapéutico , Humanos , Perdida de Seguimiento , Masculino , Registros Médicos , Persona de Mediana Edad , Cooperación del Paciente , Priapismo/etiología , Estudios Prospectivos , Tartamudeo/tratamiento farmacológico
SELECCIÓN DE REFERENCIAS
DETALLE DE LA BÚSQUEDA
...